IP Library Granted Patent US 8,414,814
Granted Patent B2
US 8,414,814 · App. 12/897,463 · Granted Apr 9, 2013

Temporal intraluminal stent, methods of making and using

Inventors: Shih-Horng Su (Irvine, CA); Debashis Dutta (Irvine, CA)
Assignee: Biosensors International Group, Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,414,814
App. No.
12/897,463
Granted
Apr 9, 2013
Kind
B2
Abstract

A biodegradable polymer stent with radiopacity and a method of making and using a stent with enhanced mechanical strength and/or controlled degradation for use in a bodily lumen is described.

Claims (14)

1. A method of making a polymer stent with enhanced mechanical strength comprising the steps of:

(a) dip-coating a mandrel with a solution comprising one or more biocompatible polymers to form a polymer tube;

(b) spin-drying the polymer tube around its longitudinal axis;

(c) solvent-polishing and vacuum drying the polymer tube;

(d) repeating steps a-c until the polymer tube reaches a desired thickness;

(e) necking the polymer tube by drawing the mandrel bearing the polymer tube through one or more necking dies of decreasing diameter, wherein said necking is carried out at a temperature above the glass transition temperature of the polymer and below the melting temperature of the polymer;

(f) annealing the polymer tube with an inert gas;

(g) removing the polymer tube from the mandrel; and

(h) creating a design in said polymer tube.

2. The method of claim 1 , wherein said design is created by laser cutting said polymer tube.

3. The method of claim 1 , wherein the solution comprising one or more biocompatible polymers also comprises one or more active pharmaceutical ingredients.

4. The method of claim 1 , wherein the solution comprising one or more biocompatible polymers is used in all repetitions of the dip-coating step.

5. The method of claim 1 , wherein said solution comprising one or more biocompatible polymers comprises at least two solutions and said repeating step comprises dip-coating the mandrel in a different solution in each repetition.

6. The method of claim 1 , wherein one or more biocompatible polymers forming the polymer tube includes an iodinated contrast agent.

Continuity (3)
Continuation 11693684 · Mar 29, 2007
Provisional Application 60862939 · Oct 25, 2006
Related Publication 20110106236A1 · May 5, 2011